The G-Rex® Grant Program

Accelerating Cell and Gene Therapy!

Empowering CGT Manufacturers with Resources and Expertise

The G-Rex® Grant Program is a $30 million initiative by ScaleReady, Wilson Wolf Manufacturing, Bio-Techne, and CellReady, that is designed to propel the advancement of cell and gene therapies (CGT).

Over 250 groups engaged in pre-clinical research, process development, and cGMP manufacturing of cell and gene-modified cell therapies, are taking advantage of this program right now!

Benefits

Proven path to highly efficient, high-throughput manufacturing operations
Lean business models that stretch investor capital
Streamlined and mistake-free transition from research labs to GMP manufacturing
Clinically scalable manufacturing transfer from academia to the private sector

What Grant Recipients Received

$5,000 to $300,000 of best-in-class products including:

- G-Rex® “M”series bioreactors and GatheRex
- Specialty reagents designed for G-Rex® including:
- Media (Animal Free, T-cell, NK)
- GMP cytokines (IL-7, IL15, IL-2. IL-21)
- TcBuster

Unlimited expert consulting services at zero cost, including:

- - Batch record review and optimization
  - Guidance from highly experienced personnel including former FDA and EMA CMC reviewers
  - Technical application support
  - CGT business and operational efficiency consulting based on years of experience

Thank You for Your Interest in the G-Rex Grant Program.

Submissions are currently closed.

Although submissions are no longer being accepted, in the spirit of innovation and discovery that inspired the G-Rex Grant Program, ScaleReady is still excited to provide free support and free product anywhere we can.

Tell us what you are working on, and let’s carry the industry forward together!